| Iris N Torres, MD | |
|
5471 W Waterford Ln, Appleton, WI 54913-8510 | |
| (920) 731-7445 | |
| Not Available |
| Full Name | Iris N Torres |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 5471 W Waterford Ln, Appleton, Wisconsin |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558308577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 50624 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thedacare Regional Med Ctr - Neenah | Neenah, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Partnership Community Health Center Inc | 2062452600 | 7 |
News Archive
Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids.
Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.
Dr. Reddy's Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the United States Securities and Exchange Commission.
› Verified 4 days ago
| Entity Name | Partnership Community Health Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225074008 PECOS PAC ID: 2062452600 Enrollment ID: O20140213001404 |
News Archive
Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids.
Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.
Dr. Reddy's Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the United States Securities and Exchange Commission.
› Verified 4 days ago
| Entity Name | Mosaic Family Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548653389 PECOS PAC ID: 4082925243 Enrollment ID: O20150616000255 |
News Archive
Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids.
Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.
Dr. Reddy's Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the United States Securities and Exchange Commission.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Iris N Torres, MD 5337 W Grande Market Dr, Appleton, WI 54913-8442 Ph: (920) 731-7445 | Iris N Torres, MD 5471 W Waterford Ln, Appleton, WI 54913-8510 Ph: (920) 731-7445 |
News Archive
Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids.
Cigna Corporation today reported strong third quarter 2013 results with each of the Company's business segments posting strong revenue and earnings contributions.
ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology, today announced the presentation of encouraging clinical data for the Company's lorvotuzumab mertansine (IMGN901) targeted anticancer compound at the 35th European Society for Medical Oncology (ESMO) Conference being held in Milan, Italy, October 8-12, 2010.
Dr. Reddy's Laboratories Limited today announced that its Annual Report on Form 20-F, containing its annual consolidated financial statements for the fiscal year ended 31 March, 2010 was filed with the United States Securities and Exchange Commission.
› Verified 4 days ago
Michael John Van Abel, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 | |
Stephen C Fuller, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 | |
Samuel James Heiks, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3916 N Intertech Ct, Appleton, WI 54913 Phone: 920-996-1000 Fax: 920-996-1054 | |
Brittany E Goodrich-braun, Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 | |
Dirk Jon Derksen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10 Wagon Wheel Dr, Appleton, WI 54913 Phone: 920-731-6374 | |
Ms. Cynthia Frances Susedik, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3925 N Gateway Dr, Appleton, WI 54913 Phone: 920-830-6877 Fax: 920-993-5037 | |
N Carter Noble, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3329 N Richmond St, Appleton, WI 54911 Phone: 920-380-2715 |